Stratos Wealth Advisors
IBB icon

Stratos Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Stratos Wealth Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$810K Sell
3,845
-348
-8% -$69.8K 0.04% 310
2026
Q2 		$798K Buy
4,193
+223
+6% +$38.3K 0.04% 316
2026
Q1 		$670K Buy
3,970
+35
+0.9% +$5.98K 0.04% 341
2025
Q4 		$664K Sell
3,935
-51
-1% -$8.28K 0.03% 380
2025
Q3 		$575K Buy
3,986
+154
+4% +$21K 0.03% 431
2025
Q2 		$485K Sell
3,832
-62
-2% -$7.61K 0.03% 456
2025
Q1 		$498K Buy
3,894
+1
+0% +$136 0.03% 431
2024
Q4 		$515K Sell
3,893
-109
-3% -$15.3K 0.02% 462
2024
Q3 		$583K Hold
4,002
– – 0.03% 461
2024
Q2 		$549K Sell
4,002
-23
-0.6% -$3.07K 0.03% 449
2024
Q1 		$552K Buy
4,025
+222
+6% +$30.3K 0.03% 437
2023
Q4 		$517K Sell
3,803
-621
-14% -$75.8K 0.03% 458
2023
Q3 		$541K Sell
4,424
-280
-6% -$35.6K 0.04% 418
2023
Q2 		$597K Sell
4,704
-89
-2% -$11.6K 0.04% 404
2023
Q1 		$619K Buy
4,793
+43
+0.9% +$5.63K 0.05% 380
2022
Q4 		$624K Buy
4,750
+949
+25% +$123K 0.05% 363
2022
Q3 		$445K Sell
3,801
-19
-0.5% -$2.36K 0.05% 367
2022
Q2 		$449K Sell
3,820
-234
-6% -$27.8K 0.04% 380
2022
Q1 		$528K Sell
4,054
-7,578
-65% -$987K 0.04% 371
2021
Q4 		$1.78M Sell
11,632
-5,876
-34% -$910K 0.13% 203
2021
Q3 		$2.83M Sell
17,508
-4,883
-22% -$822K 0.24% 115
2021
Q2 		$3.66M Sell
22,391
-1,593
-7% -$245K 0.32% 83
2021
Q1 		$3.61M Buy
23,984
+5,860
+32% +$931K 0.38% 71
2020
Q4 		$2.75M Buy
18,124
+4,570
+34% +$653K 0.38% 70
2020
Q3 		$1.84M Buy
13,554
+9,564
+240% +$1.3M 0.45% 58
2020
Q2 		$545K Buy
3,990
+978
+32% +$125K 0.17% 134
2020
Q1 		$325K Sell
3,012
-65
-2% -$7.48K 0.23% 101
2019
Q4 		$371K Sell
3,077
-106
-3% -$11.8K 0.21% 106
2019
Q3 		$317K Sell
3,183
-329
-9% -$34.4K 0.12% 176
2019
Q2 		$383K Buy
3,512
+8
+0.2% +$851 0.15% 145
2019
Q1 		$392K Sell
3,504
-220
-6% -$24.1K 0.21% 125
2018
Q4 		$359K Buy
+3,724
New +$395K 0.24% 124

Other funds holding IBB

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Commerce Bank
Commerce Bank Kansas City, Missouri $22.9B AUM 22.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

Stratos Wealth Advisors's IBB Position: Q3 2026 in Review

Stratos Wealth Advisors reduced its iShares Biotechnology ETF (IBB) stake by 8.3% in Q3 2026, selling an estimated $69.8K and leaving 3,845 shares worth $810K. The position accounts for 0.04% of the portfolio, ranked #310.

Stratos Wealth Advisors first reported a position in IBB in Q4 2018 and has held it in 32 quarters since. The position peaked at $3.66M in Q2 2021. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Stratos Wealth Advisors held 3,845 shares of iShares Biotechnology ETF worth $810K as of Q3 2026.
  • Stratos Wealth Advisors sold 348 iShares Biotechnology ETF shares in Q3 2026, an estimated $69.8K.
  • iShares Biotechnology ETF made up 0.04% of Stratos Wealth Advisors's portfolio in Q3 2026, its #310 holding.
  • Stratos Wealth Advisors first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 32 quarters since.
  • Stratos Wealth Advisors's iShares Biotechnology ETF position peaked at $3.66M in Q2 2021.
  • 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Stratos Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.